Commentary
Published in:
Volume 2 / Year 2013 / Issue 3
Volume 2 / Year 2013 / Issue 3
Biosimilar monoclonal antibodies—challenges and opportunities in Europe
Author(s): Professor Andrea Laslop, MD
Page: 110-1
Page: 110-1
Abstract: New regulations for the development of biosimilars have been introduced in Europe and a new class of biosimilars – monoclonal antibodies – is expected on the market soon, which… Read More »
Commentary on the recommendations of the European Society for Organ Transplantation Advisory Committee on generic substitution of immunosuppressive drugs
Author(s): Professor Teun van Gelder, MD, PhD
Page: 108-9
Page: 108-9
Abstract: In 2010, the Council of the European Society for Organ Transplantation formed an Advisory Committee to formulate recommendations on the use of generic drugs in solid organ transplant recipients.… Read More »
Ongoing initiatives in the Republic of Srpska to enhance prescribing efficiency; influence and future directions
Page: 112-3
Abstract: Dr Brian Godman reviews the paper by Markovic-Pekovic et al. regarding recent reforms in the Republic of Srpska. These include prescribing restrictions where concerns with the value of products… Read More »